Market News AIOpen the app

Zai Lab is moving forward with its skin treatment after good early trial results.

TrialRead the original at Benzinga
Good for ZLAB

Zai Lab reported strong signal blocking, a long-lasting drug level, and no serious safety problems in 48 healthy volunteers. These findings support ZL-1503, but they do not show it works in patients, and further results are expected in 2027.

ZLAB · Zai Lab Limited

AI read · Good for ZLAB

The AI's read

These results give Zai Lab an encouraging early sign: the drug blocked disease-linked signals and caused no reported serious safety problems. But the study involved healthy volunteers, not people with skin disease. Tests in patients are still underway, with more results expected in 2027.

Get alerts for ZLAB

Follow Zai Lab Limited (ZLAB) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ZLAB
Free on the App Store and Google Play, or on the web.